Principal component analysis of binding energies for single-point mutants of hT2R16 bound to an agonist correlate with experimental mutant cell response.
Directed evolution is a technique that enables the identification of mutants of a particular protein that carry a desired property by successive rounds of random mutagenesis, screening, and selection. This technique has many applications, including the development of G protein-coupled receptor-based biosensors and designer drugs for personalized medicine. Although effective, directed evolution is not without challenges and can greatly benefit from the development of computational techniques to predict the functional outcome of single-point amino acid substitutions. In this article, we describe a molecular dynamics-based approach to predict the effects of single amino acid substitutions on agonist binding (salicin) to a human bitter taste receptor (hT2R16). An experimentally determined functional map of single-point amino acid substitutions was used to validate the whole-protein molecular dynamics-based predictive functions. Molecular docking was used to construct a wild-type agonist-receptor complex, providing a starting structure for single-point substitution simulations. The effects of each single amino acid substitution in the functional response of the receptor to its agonist were estimated using three binding energy schemes with increasing inclusion of solvation effects. We show that molecular docking combined with molecular mechanics simulations of single-point mutants of the agonist-receptor complex accurately predicts the functional outcome of single amino acid substitutions in a human bitter taste receptor.
1 Biological Sciences Department, California State Polytechnic University Pomona , Pomona, California.
Derek E
DE
Chen
Darryl L
DL
Willick
Joseph B
JB
Ruckel
Wely B
WB
Floriano
D019943:Amino Acid Substitution; D001592:Benzyl Alcohols / Q000737:chemistry / Q000494:pharmacology; D020013:Calcium Signaling / Q000187:drug effects / Q000235:genetics; D016861:Cyclooxygenase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D005960:Glucosides / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D056004:Molecular Dynamics Simulation; D017354:Point Mutation; D017434:Protein Structure, Tertiary; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship; D000098706:Taste Receptors, Type 2
D001592:Benzyl Alcohols; D016861:Cyclooxygenase Inhibitors; D005960:Glucosides; D043562:Receptors, G-Protein-Coupled; D000098706:Taste Receptors, Type 2; C005696:salicin
GPCR selectivity; GPCR specificity; bitter taste; directed evolution; hT2R16; human bitter taste receptor 16; ligand binding; molecular dynamics; mutation simulations; single amino acid substitutions